Pennesi, E., Brivio, E., Ammerlaan, A. C. J., Jiang, Y., van der Velden, V. H. J., Beverloo, H. B., Sleight, B., Locatelli, F., Brethon, B., Rossig, C., Engstler, G., Nilsson, A., Bruno, B., Petit, A., Bielorai, B., Rizzari, C., Rialland, F., Rubio-San-Simón, A., Sirvent, F. J. B., Diaz-de-Heredia, C., Rives, S. and Zwaan, C. M. (2024) “Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22<sup>+</sup&gt; acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial”, Haematologica. Pavia, Italy, 109(10), pp. 3157-3166. doi: 10.3324/haematol.2023.284409.